Pei-Chieng Cha
Impact in
- Pharmacology top 5%
- Pharmacogenetics and Drug Metabolism
- Obstetrics and Gynecology top 10%
- Uterine Myomas and Treatments
- Gynecological conditions and treatments
Papers in
-
- Intracranial Aneurysms: Treatment and Complications 2
- Parkinson's Disease Mechanisms and Treatments 2
- Co-authors
- Naoyuki Kamatani (6 shared papers)Atsushi Takahashi (5 shared papers)Michiaki Kubo (4 shared papers)Yusuke Nakamura (4 shared papers)Siew‐Kee Low (3 shared papers)Hitoshi Zembutsu (4 shared papers)Taisei Mushiroda (3 shared papers)Naoya Hosono (2 shared papers)
In The Last Decade
Pei-Chieng Cha
16 papers receiving 487 citations
Peers
Comparison fields: 5 of 68
- Pharmacology 102
- Obstetrics and Gynecology 68
- Reproductive Medicine 54
- Neurology 91
- Rheumatology 42
Countries citing papers authored by Pei-Chieng Cha
This map shows the geographic impact of Pei-Chieng Cha's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pei-Chieng Cha with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pei-Chieng Cha more than expected).
Fields of papers citing papers by Pei-Chieng Cha
This network shows the impact of papers produced by Pei-Chieng Cha. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pei-Chieng Cha. The network helps show where Pei-Chieng Cha may publish in the future.
Co-authors
The 25 scholars most cited alongside Pei-Chieng Cha, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 101 | |
| 2 | 2012 | 92 | |
| 3 | 2011 | 88 | |
| 4 | 2009 | 36 | |
| 5 | 2012 | 33 | |
| 6 | 2018 | 32 | |
| 7 | 2011 | 28 | |
| 8 | 2012 | 23 | |
| 9 | 2007 | 21 | |
| 10 | 2020 | 12 | |
| 11 | 2020 | 10 | |
| 12 | 2004 | 8 | |
| 13 | 2015 | 5 | |
| 14 | 2022 | 2 | |
| 15 | 2025 | 1 | |
| 16 | 2017 | 1 |
About Pei-Chieng Cha
Pei-Chieng Cha is a scholar working on Molecular Biology, Neurology, Genetics, Cellular and Molecular Neuroscience and Pharmacology, having authored 16 papers that have together received 493 indexed citations. Recurring topics across this work include Nuclear Receptors and Signaling (3 papers), Pharmacogenetics and Drug Metabolism (3 papers), Genetics and Neurodevelopmental Disorders (2 papers), Drug Transport and Resistance Mechanisms (2 papers), Intracranial Aneurysms: Treatment and Complications (2 papers), Genetic Syndromes and Imprinting (2 papers), Parkinson's Disease Mechanisms and Treatments (2 papers) and Vitamin K Research Studies (1 paper). The work is most often cited by research in Pharmacology (102 citations), Obstetrics and Gynecology (68 citations), Reproductive Medicine (54 citations), Neurology (91 citations) and Rheumatology (42 citations). Pei-Chieng Cha has collaborated with scholars based in Japan, China and Malaysia. Frequent co-authors include Naoyuki Kamatani, Atsushi Takahashi, Michiaki Kubo, Yusuke Nakamura, Siew‐Kee Low, Hitoshi Zembutsu, Taisei Mushiroda, Naoya Hosono, Yasukazu Nakamura and Atsushi Takahashi. Their work appears in journals such as Human Molecular Genetics, Journal of the Neurological Sciences, Journal of Neurology Neurosurgery & Psychiatry, Nature Genetics and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.